Diane Finegood
Affiliations: | Simon Fraser University, Burnaby, British Columbia, Canada |
Area:
Physiology Biology, Neuroscience BiologyGoogle:
"Diane Finegood"Mean distance: 53433
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Suskin NG, Heigenhauser G, Afzal R, et al. (2007) The effects of exercise training on insulin resistance in patients with coronary artery disease. European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups On Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology. 14: 803-8 |
Hamilton J, Cummings E, Zdravkovic V, et al. (2003) Metformin as an adjunct therapy in adolescents with type 1 diabetes and insulin resistance: a randomized controlled trial. Diabetes Care. 26: 138-43 |
Legro RS, Finegood D, Dunaif A. (1999) A Fasting Glucose To Insulin Ratio Is A Useful Measure Of Insulin Sensitivity In Women With Polycystic Ovary Syndrome Obstetrical & Gynecological Survey. 54: 35-36 |
Legro RS, Finegood D, Dunaif A. (1998) A Fasting Glucose to Insulin Ratio Is a Useful Measure of Insulin Sensitivity in Women with Polycystic Ovary Syndrome The Journal of Clinical Endocrinology and Metabolism. 83: 2694-2698 |
Dunaif A, Scott D, Finegood D, et al. (1997) The Insulin-Sensitizing Agent Troglitazone Improves Metabolic and Reproductive Abnormalities in the Polycystic Ovary Syndrome Obstetrical & Gynecological Survey. 52: 110-111 |
Dunaif A, Scott D, Finegood D, et al. (1996) The Insulin-Sensitizing Agent Troglitazone Improves Metabolic and Reproductive Abnormalities in the Polycystic Ovary Syndrome* The Journal of Clinical Endocrinology and Metabolism. 81: 3299-3306 |
Kneteman NM, Lakey JRT, Wagner T, et al. (1996) The metabolic impact of rapamycin (sirolimus) in chronic canine islet graft recipients Transplantation. 61: 1206-1210 |
Hramiak I, Dupre J, Finegood D. (1992) Determinants of prolonged (> 1 year) Non-Insulin-Receiving (NIR) remission of IDDM during cyclosporine A (CsA treatment) Journal of Autoimmunity. 5 |